Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Announcement Summary

For personal use only

Entity name

PARADIGM BIOPHARMACEUTICALS LIMITED..

Date of this announcement

Tuesday February 01, 2022

The +securities the subject of this notification are:

+Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends

Total number of +securities to be issued/transferred

Total number of

ASX +security

+securities to be

code

Security description

issued/transferred

Issue date

New class - code

125,000 Ordinary Shares issued at $1.89 per

125,000

25/01/2022

to be confirmed

share, restricted and in escrow until 25 Jan 2023

New class - code

125,000 Ordinary Shares issued at $1.89 per

125,000

25/01/2022

to be confirmed

share, restricted and in escrow until 25 Jan 2024

New class - code

125,000 Ordinary Shares issued at $1.89 per

125,000

25/01/2022

to be confirmed

share, restricted and in escrow until 25 Jan 2025

Refer to next page for full details of the announcement

Notification of Issue, Conversion or Payment up of Unquoted

1 / 10

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 1 - Entity and announcement details

For personal use only

1.1 Name of entity

PARADIGM BIOPHARMACEUTICALS LIMITED..

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2

Registered number type

Registration number

ABN

94169346963

1.3

ASX issuer code

PAR

  1. The announcement is New announcement
  2. Date of this announcement

1/2/2022

Notification of Issue, Conversion or Payment up of Unquoted

2 / 10

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 2 - Issue details

For personal use only

2.1 The +securities the subject of this notification are:

+Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:

does not have an existing ASX security code ("new class")

Notification of Issue, Conversion or Payment up of Unquoted

3 / 10

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX

in an Appendix 3B

only

New +securities issued under an +employee incentive scheme

ASX +security code

+Security description

New class - code to be confirmed

125,000 Ordinary Shares issued at $1.89 per share,

restricted and in escrow until 25 Jan 2023

+Security type

ISIN code

use

Ordinary fully or partly paid shares/units

Date the +securities the subject of this notification were issued

25/1/2022

Will all the +securities issued in this class rank equally in all respects from their issue date?

personal

Yes

Were any of the +securities issued to +key management personnel (KMP) or an +associate?

Yes

Provide details of the KMP or +associates being issued +securities.

Name of KMP

Name of registered holder

Number of +securities

125,000

Donna Skerrett

Donna Skerrett

Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under

listing rule 6.1?

Yes

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being

issued.

O dinary fully or partly paid shares/units Details

For

+Security currency

AUD - Australian Dollar

Are there CDIs issued over the +securities?

No

Is it a Partly Paid class of +security?

No

Notification of Issue, Conversion or Payment up of Unquoted

4 / 10

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

Is it a stapled class of +security?

No

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

https://www.asx.com.au/asxpdf/20201125/pdf/44q865364w4lhs.pdf

only

Any other information the entity wishes to provide about the +securities the subject of this notification

Issue details

use

Number of +securities

125,000

personal

New +securities issued under an +employee incentive scheme

ASX +security code

+Security description

New class - code to be confirmed

125,000 Ordinary Shares issued at $1.89 per share,

restricted and in escrow until 25 Jan 2024

+Security type

ISIN code

Ordinary fully or partly paid shares/units

Date the +securities the subject of this notification were issued

25/1/2022

Will all the +securities issued in this class rank equally in all respects from their issue date?

For

Yes

Were any of the +securities issued to +key management personnel (KMP) or an +associate?

Yes

Provide details of the KMP or +associates being issued +securities.

Name of KMP

Name of registered holder

Number of +securities

125,000

Donna Skerrett

Donna Skerrett

Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1?

Yes

Notification of Issue, Conversion or Payment up of Unquoted

5 / 10

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Paradigm Biopharmaceuticals Ltd. published this content on 01 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 February 2022 05:21:07 UTC.